辰欣药业股份有限公司关于持股5%以上股东减持股份计划公告

Group 1 - The major shareholder Han Yanzhen holds 31,977,829 shares of Chenshin Pharmaceutical, accounting for 7.06% of the total share capital before the reduction plan [2] - Han Yanzhen plans to reduce holdings through centralized bidding and block trading, with a total reduction not exceeding 13,582,623 shares, or 3% of the total share capital [2] - The reduction plan will be adjusted if there are changes in the company's capital structure during the reduction period [2][3] Group 2 - The reduction plan is based on the shareholder's personal financial needs and will not significantly impact the company's governance structure or ongoing operations [5] - The implementation of the reduction plan is subject to market conditions, and the timing, quantity, and price of the reduction are uncertain [5] - The reduction plan complies with relevant laws and regulations, and the company will ensure timely disclosure of information during the implementation [7]